• Q3FY19 MFS CONSOLIDATED REVENUES: Rs. 4,124 Cr., UP 12%
  • MAX LIFE’S EV ON MCEV BASIS AS ON 31ST DECEMBER 2018 AT: RS. 8,254 CR; OPERATING RoEV 18.8%
  • MAX LIFE’S NBM FOR Q3FY19 EXPANDS TO 22.8% (AT STRUCTURAL COSTS); VALUE OF NEW BUSINESS (POST-OVERRUN COSTS) WAS RS. 466 CR.
  • HIGHEST EVER CLAIMS PAID RATIO FOR MAX LIFE AT: 98.26% FOR 2017-18
  • MAX LIFE’S INDIVIDUAL ADJUSTED SALES FOR: 9MYTD GREW BY 21%